Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 4/2019

01-12-2019 | Lymphoma | Case Report

Extranodal Marginal Zone B Cell (MALT) Lymphoma of the Esophagus

Authors: James H. Tabibian, Amir Kalani, Anna M. Moran, Kashyap Panganamamula

Published in: Journal of Gastrointestinal Cancer | Issue 4/2019

Login to get access

Excerpt

Approximately, one-quarter of all non-Hodgkin’s lymphoma cases manifest extranodally, half of which are located in the gastrointestinal tract. The majority of the cases are mature B cell neoplasms which arise in the stomach and are highly associated with H. pylori infection [1]. In contrast, primary esophageal lymphoma is exceedingly rare, with only 18 cases reported to date in the world literature, nearly all of which are from Eastern Asia [2, 3]. Moreover, primary esophageal lymphoma does not have a clear association with H. pylori. Due to the rare occurrence of esophageal mucosa-associated lymphoid tissue (MALT) lymphoma, there is a paucity of data regarding clinical findings, endoscopic features, treatment regimen, and overall prognosis. …
Literature
1.
go back to reference Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee meeting, Airlie house, Virginia, November, 1997. Ann Oncol. 1999;10(12):1419–32.CrossRef Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee meeting, Airlie house, Virginia, November, 1997. Ann Oncol. 1999;10(12):1419–32.CrossRef
2.
go back to reference Okerbloom JA, Armitage JO, Zetterman R, Linder J. Esophageal involvement by non-Hodgkin’s lymphoma. Am J Med. 1984;77(2):359–61.CrossRef Okerbloom JA, Armitage JO, Zetterman R, Linder J. Esophageal involvement by non-Hodgkin’s lymphoma. Am J Med. 1984;77(2):359–61.CrossRef
3.
go back to reference Ma Q, Zhang C, Fang S, Zhong P, Zhu X, Lin L, et al. Primary esophageal mucosa-associated lymphoid tissue lymphoma: a case report and review of literature. Medicine (Baltimore). 2017;96(13):e6478.CrossRef Ma Q, Zhang C, Fang S, Zhong P, Zhu X, Lin L, et al. Primary esophageal mucosa-associated lymphoid tissue lymphoma: a case report and review of literature. Medicine (Baltimore). 2017;96(13):e6478.CrossRef
4.
go back to reference Tarui T, Ishikawa N, Kadoya S, Watanabe G. Co-occurrence of papillary thyroid cancer and MALT lymphoma of the thyroid with severe airway obstruction: a case report and review of the literature. Int J Surg Case Rep. 2014;5(9):594–7.CrossRef Tarui T, Ishikawa N, Kadoya S, Watanabe G. Co-occurrence of papillary thyroid cancer and MALT lymphoma of the thyroid with severe airway obstruction: a case report and review of the literature. Int J Surg Case Rep. 2014;5(9):594–7.CrossRef
5.
go back to reference Weissferdt A, Moran CA. Primary MALT-type lymphoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Lung. 2011;189(6):461–6.CrossRef Weissferdt A, Moran CA. Primary MALT-type lymphoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Lung. 2011;189(6):461–6.CrossRef
6.
go back to reference Gezen C, Kement M, Oncel M, Tuncay E, Sahlepci T, Alkan S. Mucosa associated lymphoid tissue lymphoma of the colon: a case report. Cases J. 2009;2:9316.CrossRef Gezen C, Kement M, Oncel M, Tuncay E, Sahlepci T, Alkan S. Mucosa associated lymphoid tissue lymphoma of the colon: a case report. Cases J. 2009;2:9316.CrossRef
7.
go back to reference Terada T. CD5-positive marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) of the lung. Diagn Pathol. 2012;7:16.CrossRef Terada T. CD5-positive marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) of the lung. Diagn Pathol. 2012;7:16.CrossRef
8.
go back to reference Delli FS, Zaraboukas T, Mandekou-Lefaki I. Primary MALT type skin lymphoma-is ‘Wait and See’ a possible strategy? Clin Med Oncol. 2008;2:153–8.PubMedPubMedCentral Delli FS, Zaraboukas T, Mandekou-Lefaki I. Primary MALT type skin lymphoma-is ‘Wait and See’ a possible strategy? Clin Med Oncol. 2008;2:153–8.PubMedPubMedCentral
9.
go back to reference Toso A, Aluffi P, Capello D, Conconi A, Gaidano G, Pia F. Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands. Head Neck. 2009;31(9):1181–7.CrossRef Toso A, Aluffi P, Capello D, Conconi A, Gaidano G, Pia F. Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands. Head Neck. 2009;31(9):1181–7.CrossRef
10.
go back to reference Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol. 2010;7(6):336–46.CrossRef Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol. 2010;7(6):336–46.CrossRef
11.
go back to reference Hu C, Yi C, Dai X. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol. 2006;21(4):722–6.CrossRef Hu C, Yi C, Dai X. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol. 2006;21(4):722–6.CrossRef
12.
go back to reference Kishi K, Maeda H, Nakamura Y, Shirai S, Sato M. Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion. Int J Clin Oncol. 2012;17(2):174–80.CrossRef Kishi K, Maeda H, Nakamura Y, Shirai S, Sato M. Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion. Int J Clin Oncol. 2012;17(2):174–80.CrossRef
Metadata
Title
Extranodal Marginal Zone B Cell (MALT) Lymphoma of the Esophagus
Authors
James H. Tabibian
Amir Kalani
Anna M. Moran
Kashyap Panganamamula
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-00187-5

Other articles of this Issue 4/2019

Journal of Gastrointestinal Cancer 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.